Full-Time

Senior Tax Analyst

Posted on 6/19/2026

Zeiss

Zeiss

1,001-5,000 employees

Manufactures high-precision optical instruments and devices

Compensation Overview

$91k - $113k/yr

Company Does Not Provide H1B Sponsorship

White Plains, NY, USA

In Person

Category
Accounting (1)
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Bachelor’s degree in Accounting; Master of Taxation preferred.
  • Minimum of 5 years of strong corporate tax experience from public accounting firms or large multinational corporations.
  • Extensive background in federal and multistate income tax compliance.
  • Solid tax accounting experience (ASC 740), including tax provision preparation and maintenance, and reconciliation of current and deferred tax accounts.
  • Comprehensive proficiency in Microsoft Office programs, specifically Excel and Word.
  • Experience with ONESOURCE Income Tax preferred.
  • Excellent organizational skills and attention to detail.
Responsibilities
  • Prepare federal and multistate income tax returns, including separate company, consolidated, and unitary filings, ensuring accuracy and timeliness.
  • Calculate and prepare quarterly estimated tax payments and extension tax payments.
  • Maintain and manage the tax calendar to ensure all deadlines are met.
  • Prepare and assist with filing Form 5471s, 5472s, 1042S, 1120F, and other miscellaneous tax forms.
  • Prepare mid-year and year-end tax provisions, including related footnotes and journal entries.
  • Maintain, update, and reconcile current and deferred tax accounts to ensure accuracy.
  • Conduct research on technical tax matters to stay informed of relevant tax laws and regulations.
  • Provide practical, solution-focused responses to tax issues.
  • Effectively communicate tax-related information verbally and in writing to both tax and non-tax personnel.
  • Assist with income tax audits and correspondence.
  • Respond promptly to notices from various tax authorities.
  • Take initiatives on process improvement to enhance efficiency and effectiveness.
  • Work collaboratively with internal employees and external individuals on various projects.
Desired Qualifications
  • Master of Taxation preferred.
  • Experience with ONESOURCE Income Tax preferred.

ZEISS is a global leader in optics and optoelectronics, serving medical professionals, industrial manufacturers, consumers, and the semiconductor industry. It designs and sells high-precision optical instruments, medical devices, semiconductor manufacturing equipment, and vision care products such as corrective lenses and eye-health services. Its products rely on advanced optics and imaging technologies to deliver accurate inspection, diagnosis, and manufacturing outcomes across healthcare, industrial quality control, consumer optics, and chip fabrication. What sets ZEISS apart is its breadth and depth: a long-standing scale in multiple markets, integrated solutions across optics, imaging, metrology, and precision engineering, and a commitment to sustainability in electricity use and carbon emissions. The company’s goal is to advance optics and optoelectronics by providing reliable, high-quality tools and services worldwide while operating in a sustainable way.

Company Size

1,001-5,000

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$65.3M

Headquarters

Oberkochen, Germany

Founded

2001

Your Connections

People at Zeiss who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Medical Technology grew to €2.704 billion in fiscal 2024/25.
  • AI patient engagement and cloud referral tools expand ZEISS's ophthalmology software footprint.
  • Semiconductor Manufacturing Technology benefits from EUV lithography demand and high switching costs.

What critics are saying

  • ASML sourcing changes can compress ZEISS's semiconductor optics revenue and margins.
  • Ophthalmology hardware faces Alcon and J&J competition in premium cataract systems.
  • Privacy or interoperability failures would undermine ZEISS's cloud clinical workflow adoption.

What makes Zeiss unique

  • ZEISS spans semiconductor lithography, medical technology, industrial metrology, and consumer optics.
  • Its ophthalmology stack links diagnostics, surgical visualization, workflow software, and vision-care products.
  • The company combines 175-plus years of optical engineering with global manufacturing and R&D.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Paid Vacation

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

-2%

1 year growth

-2%

2 year growth

-2%
PR Newswire
Apr 2nd, 2026
ZEISS unveils AI-powered patient platform and enhanced IOL tools at ASCRS

ZEISS has unveiled new digital, AI and surgical innovations for cataract and refractive workflows at the ASCRS conference. The medical technology company is expanding its US cataract portfolio with new irrigation/aspiration handpieces compatible with the DORC EVA NEXUS surgical system, alongside enhanced IOL calculation capabilities for the ZEISS IOLMaster 700. ZEISS also launched VisioGen commercially in the US, a human-verified AI patient engagement platform for ophthalmology practices. The platform integrates with clinic websites to capture patient demand around the clock, with AI-assisted responses reviewed by ZEISS-trained optometrists before delivery. The company showcased ZEISS Collaborative Care, a cloud-based application enabling secure data sharing between eye care professionals, and previewed ZEISS CLINIC 360, pending FDA clearance. ZEISS is celebrating 100 years of US operations this year.

PR Newswire
Mar 24th, 2026
ZEISS expands ophthalmic portfolio in Canada with new diagnostic lasers and workflow tools

ZEISS Medical Technology has expanded its ophthalmic workflow portfolio in Canada with new diagnostic, visualisation and therapeutic solutions. The company will showcase the innovations at upcoming Canadian ophthalmology conferences in Ottawa and Montréal. Key additions include ICGA for ZEISS CLARUS 700, offering simultaneous FA and ICG capture for clinical assessment, and ZEISS VISULAS green with selective laser trabeculoplasty for retinal photocoagulation. The company has introduced refraction devices ZEISS VISUREF 600 and ZEISS VISUCORE 500 to streamline diagnostic workflows. ZEISS also launched VISULAS yag, a new-generation therapeutic laser for anterior segment photodisruption within cataract workflows. The ZEISS FORUM subscription package, now available in Canada, offers integrated data management with unlimited device licences and lower upfront costs.

PR Newswire
Feb 23rd, 2026
ZEISS launches Collaborative Care app for eye care professionals with cloud and on-premises options

ZEISS Medical Technology has launched Collaborative Care, a browser-based application enabling eye care professionals to share data securely, refer patients and coordinate clinical care. Built on the ZEISS Health Data Platform, the solution addresses fragmented data sharing and inefficient referral processes in ophthalmic care. The application offers flexible deployment as either a standalone cloud solution or an integrated extension of ZEISS FORUM. Key features include secure exchange of images and reports, streamlined referral workflows with tracking capabilities, and tools for building professional networks between optometrists and ophthalmologists. ZEISS Collaborative Care was demonstrated at industry events in London and Orlando in February and March 2026. The company generated €2,228 million in revenue in fiscal year 2024/25 with 5,784 employees worldwide.

Handelsblatt
Feb 19th, 2026
Custom Surgical raises $4M to develop AI-powered ophthalmology platform

Custom Surgical, a German ophthalmology company, has raised €3.5 million to advance its platform. The funding will support development of AI-powered features including automated image optimisation and assisted triage processes that help determine case urgency and specialist assignment. The company is already developing its first AI-based triage and screening system. The technology aims to provide initial assessments that guide decisions on how urgently cases need attention and which medical professionals should handle them next.

Investors Hangout
Feb 18th, 2026
Mindpeak raises $15.3M Series A to scale AI cancer diagnostic tools

Mindpeak, an AI-driven pathology startup, raised $15.3 million in a Series A round led by ZEISS Ventures and InnoVentureFund in 2024. The funding will accelerate development and deployment of the company's AI diagnostic tools for cancer pathology. Founded in 2018, Mindpeak's algorithms have supported over 30,000 patient diagnoses across US and European healthcare markets. The technology uses automated histological analyses to help pathologists make faster, more precise clinical decisions. CEO Felix Faber stated the capital would expedite product rollouts and expand capabilities. The company has established strategic partnerships with major players including Roche. Mindpeak operates in the rapidly growing digital pathology market, driven by technological innovation and increasing demand for advanced diagnostic services in an ageing population.